Back to Search Start Over

Magnetic resonance imaging for cerebral lesions during minimal invasive mitral valve surgery: study protocol for a randomized controlled trial.

Authors :
Barbero, Cristina
Ricci, Davide
Stura, Erik Cura
Pellegrini, Augusto
Marchetto, Giovanni
ElQarra, Suad
Boffini, Massimo
Passera, Roberto
Valentini, Maria Consuelo
Rinaldi, Mauro
Cura Stura, Erik
Source :
Trials; 2/21/2017, Vol. 18, p1-6, 6p, 1 Diagram, 2 Charts
Publication Year :
2017

Abstract

<bold>Background: </bold>Recent data have highlighted a higher rate of neurological injuries in minimal invasive mitral valve surgery (MIMVS) compared with the standard sternotomy approach; therefore, the role of specific clamping techniques and perfusion strategies on the occurrence of this complication is a matter of discussion in the medical literature. The purpose of this trial is to prospectively evaluate major, minor and silent neurological events in patients undergoing right mini-thoracotomy mitral valve surgery using retrograde perfusion and an endoaortic clamp or a transthoracic clamp.<bold>Methods/design: </bold>A prospective, blinded, randomized controlled study on the rate of neurological embolizations during MIMVS started at the University of Turin in June 2014. Major, minor and silent neurological events are being investigated through standard neurological evaluation and magnetic resonance imaging assessment. The magnetic resonance imaging protocol includes conventional sequences for the morphological and quantitative assessment and nonconventional sequences for the white matter microstructural evaluation. Imaging studies are performed before surgery as baseline assessment and on the third postoperative day and, in patients who develop postoperative ischemic lesions, after 6 months.<bold>Discussion: </bold>Despite recent concerns raised about the endoaortic setting with retrograde perfusion, we expect to show equivalence in terms of neurological events of this technique compared with the transthoracic clamp in a selected cohort of patients. With the first results expected in December 2016 the findings would be of help in confirming the efficacy and safety of MIMVS.<bold>Trial Registration: </bold>ClinicalTrials.gov, Identifier: NCT02818166 . Registered on 8 February 2016 - trial retrospectively registered. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
17456215
Volume :
18
Database :
Complementary Index
Journal :
Trials
Publication Type :
Academic Journal
Accession number :
121417205
Full Text :
https://doi.org/10.1186/s13063-017-1821-y